Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INSTAR
2024-515350-25-01Phase 4Authorised
- Sponsor
- St. Olavs University Hospital
- Start
- Jan 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 3
01
Overview
Phase 4, randomised trial in bronchiolitis and asthma comparing Systemic corticosteroid with Placebo (2 arms). Primary endpoints: Time to new physician-confirmed wheezy episode and Time to fulfill asthma criteria. Planned start Jan 2025; status: authorised.
02
Drugs
dexamethasonebetamethasone
03
Conditions
bronchiolitisasthma
Beyond the preview
Go deeper on 2024-515350-25-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-515350-25-01.